The group has just announced the first successful in-human implantation of the BiVACOR Total Artificial Heart (TAH).
The implantation occurred as part of anFDA-approved feasibility study.
The goal is to allow these people a higher quality of life while they await a heart transplant.
This makes devices like the TAH even more critical, as they can provide a bridge in care.
Physicians have successfully implanted the BiVACOR Total Artificial Heart in a human for the first time.
